Semax, explained
A seven-amino-acid peptide registered as a medicine in Russia and never approved in the United States. What it is, what has been studied, and how to read that evidence.
Semax is a synthetic peptide developed in Russia, where it has been a registered medicine for decades. It has never been approved in the United States, and most of its research has not been repeated in trials run to US standards. This guide covers what Semax is, what has been studied, and what its status here means.
What Semax is
Semax is a chain of seven amino acids. Its first four are taken from a fragment of ACTH, a hormone made by the pituitary gland; the last three were added to make the molecule more stable. The fragment it is built on does not carry ACTH's hormonal action on the adrenal glands — researchers chose it because of that fragment's effects on the nervous system in early experiments.
What researchers have studied
Russian clinical research has examined Semax in the setting of stroke and of conditions affecting attention and memory. Laboratory work in animals has looked at its effects on the brain's own growth-factor signaling, including a protein called BDNF that is involved in how nerve cells survive and form connections.
These are descriptions of what has been studied and of mechanisms proposed from that work. They are not demonstrations, to the standard used for drug approval in the United States, of a benefit for any condition.
Where the evidence stops
Most of the human studies were conducted in Russia, many were small, and their methods are difficult to evaluate against the standards the FDA applies. Semax has not been through the FDA's review process, and there are no large trials run to that standard establishing that it is safe or effective for any condition. Long-term safety has not been characterized in that way either.
What a prescribed protocol looks like
The form, the amount, the schedule and the duration of any protocol are decisions made by the prescribing provider for the individual patient. Nothing in this article should be read as a dosing recommendation. If a source online offers you Semax without a licensed provider and a real evaluation involved, treat that as a warning sign, not a shortcut.
FDA status and compounding: what to know
The regulatory picture here deserves precision. Semax is registered as a medicine in Russia. It is not an FDA-approved medication — approval in another country does not carry over to the United States, and no product containing it has been approved by the FDA for any use. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or efficacy.
In July 2026, an FDA advisory committee reviewed whether Semax should be added to the list of substances that pharmacies may use in compounding. That review concerns what licensed pharmacies may prepare on a valid prescription. It is not an FDA approval, and it does not establish that Semax is safe or effective for any use.
Semax is not yet available through Peptivik. If and when it is offered, it will be by prescription only, after an evaluation by a licensed provider, and prepared for individual patients by state-licensed US compounding pharmacies — a different regulatory lane than FDA premarket review, and one you should expect any honest platform to disclose plainly.
If you compete in a tested sport
Anti-doping rules restrict a number of peptides, including substances that have no regulatory approval. If you are subject to drug testing, check your sport's current prohibited list before considering Semax.
Questions worth asking a provider
- What the human evidence does and does not show for the reason you are considering it.
- How it would fit alongside your current medications, especially any that act on the nervous system.
- What is known, and what is not known, about side effects and long-term safety.
- What they would want to evaluate first, and what would lead them to advise against it.
The bottom line
Semax is a seven-amino-acid synthetic peptide built on a fragment of a pituitary hormone. It is a registered medicine in Russia and has a body of research there, but it has not been reviewed or approved by the FDA for any use. Whether it is appropriate for you is a decision that belongs with a licensed provider who can weigh that evidence against your health history.
This content is educational and not a substitute for advice from your provider.